Share on Facebook
Share on Twitter
Share on LinkedIn
Share by Email
Print
Kimyrsa Generic Name & Formulations
Legal Class
Rx
General Description
Oritavancin 1200mg; per vial; lyophilized pwd for IV infusion after reconstitution and dilution; contains mannitol; preservative-free.
Pharmacological Class
Lipoglycopeptide.
How Supplied
Single-dose vial—1
Manufacturer
Generic Availability
NO
Kimyrsa Indications
Indications
Susceptible acute bacterial skin and skin structure infections (ABSSSI).
Kimyrsa Dosage and Administration
Adult
Give by IV infusion over 1hr. ≥18yrs: 1200mg as a single dose.
Children
<18yrs: not established.
Kimyrsa Contraindications
Contraindications
Use of IV unfractionated heparin sodium for 120hrs (5 days) after oritavancin administration.
Kimyrsa Boxed Warnings
Not Applicable
Kimyrsa Warnings/Precautions
Warnings/Precautions
History of glycopeptide allergy. Discontinue immediately if acute hypersensitivity reaction occurs. Consider stopping or slowing infusion if infusion-related reactions occur. Evaluate if Clostridioides difficile-associated diarrhea is suspected or confirmed. Monitor for osteomyelitis; use alternative therapy if suspected or diagnosed. Severe hepatic or renal impairment: not studied. Pregnancy. Nursing mothers.
Kimyrsa Pharmacokinetics
See Literature
Kimyrsa Interactions
Interactions
Increased risk of bleeding with concomitant warfarin; may prolong aPTT for up to 120hrs, PT/INR for up to 12hrs, and ACT for up to 24hrs; monitor for bleeding. Avoid concomitant with drugs that are predominantly metabolized by one of the affected CYP450 enzymes. May increase concentrations of CYP2C9/CYP2C19 substrates. May decrease concentrations of CYP3A4/CYP2D6 substrates. May interfere with coagulation tests; consider non-phospholipid dependent test (eg, Factor Xa assay) or alternative anticoagulant not requiring aPTT monitoring.
Kimyrsa Adverse Reactions
Adverse Reactions
Headache, nausea, vomiting, limb and subcutaneous abscesses, diarrhea; infusion-related reactions.
Kimyrsa Clinical Trials
See Literature
Kimyrsa Note
Not Applicable
Kimyrsa Patient Counseling
See Literature
